Stifel Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Raises Target Price to $78

Futu NewsNov 21 21:31 · Ratings

TD Cowen Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $65

Futu NewsNov 20 14:32 · Ratings

Canaccord Genuity Maintains Buy on Rhythm Pharmaceuticals, Maintains $80 Price Target

BenzingaNov 20 06:33 · Ratings

Rhythm Pharmaceuticals Analyst Ratings

BenzingaNov 20 06:32 · Ratings

A Quick Look at Today's Ratings for Rhythm Pharmaceuticals(RYTM.US), With a Forecast Between $58 to $80

Futu NewsNov 19 21:00 · Ratings

TD Cowen Sticks to Its Buy Rating for Rhythm Pharmaceuticals (RYTM)

TipRanksNov 19 20:26 · Ratings